468 / 1726
•
Initiative EMBRACE study group within GEC-ESTRO
•
Start inclusion 2016, 1000 patients intended
•
Aims for
EBRT and brachytherapy
•
Exclusive IMRT
•
SIB boosting for lymph node metastases
•
Extension elective field based on defined risk profile
•
………………………………….
Ongoing evidence for improving treatment planning